The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday ...

The U.S. Food and Drug Administration said on Friday it has approved Boehringer Ingelheim's drug for patients with a type of ...

Cervical cancer is highly preventable with routine screening. To provide people with a cervix a comfortable and private ...

This article was featured in One Great Story, New York ’s reading recommendation newsletter. Sign up here to get it nightly.

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline ...

Eastman Kodak Co. reported a second-quarter loss and a year-over-year drop in sales, as the company leans on a Rochester ...

A Fallen Giant Pfizer (NYSE:PFE) has been a bitter pill for investors to swallow. Down 19% from its 52-week high of $30.43 per share, PFE stock has plummeted over 50% in the past three years, a stark ...

Some oncologists and researchers have raised concerns about delays in the completion of confirmatory trials, but FDA now has new tools to push them ahead.

Generative AI technology has tremendous potential for the healthcare industry, but we shouldn’t expect too much – especially if we’re the FDA.

FDA warning letters highlight recurring patterns, systemic gaps, and evolving priorities that medical device manufacturers ...

Tonix Pharmaceuticals Holding shares have surged 62% since my Buy call, driven by optimism for Tonmya’s FDA decision. Click ...